Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 42: 1984-1991, 1996;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melegos, D. N.
Right arrow Articles by Hayaishi, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melegos, D. N.
Right arrow Articles by Hayaishi, O.

Clinical Chemistry, Vol 42, 1984-1991, Copyright © 1996 by American Association for Clinical Chemistry

Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids

DN Melegos, EP Diamandis, H Oda, Y Urade and O Hayaishi
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.

A two-site sandwich-type assay for human prostaglandin D (PGD) synthase (beta-trace) was developed with two monoclonal antibodies and using time-resolved fluorometry as the detection technique. The assay is precise (CVs < 10%), accurate, and highly specific for PGD synthase and has a detection limit of 0.05 microgram/L. Using this assay, we measured PGD synthase concentrations in serum, urine, amniotic fluid, cerebrospinal fluid (CSF), seminal plasma, breast cyst fluid, breast discharge fluid, breast milk, and breast tumor extracts. The highest concentrations were found in CSF. We identified proteolytic degradation of PGD synthase in amniotic fluid. Fetal tissues contained various amounts of the enzyme, with the highest values being found in brain and heart. In placental extracts, PGD synthase content was greatest at 11- 28 weeks of gestation-in accordance with the concentrations measured in amniotic fluids for this gestational period. We conclude that PGD synthase is ubiquitous and is present in many fluids and tissues of adults and fetuses. This first quantitative and sensitive assay of PGD synthase should facilitate expansion of knowledge on this enzyme and possibly will have applications for diagnosis and monitoring of human diseases.


The following articles in journals at HighWire Press have cited this article:


Home page
 Arch Otolaryngol Head Neck SurgHome page
A. Warnecke, T. Averbeck, U. Wurster, M. Harmening, T. Lenarz, and T. Stover
Diagnostic Relevance of {beta}2-Transferrin for the Detection of Cerebrospinal Fluid Fistulas
Arch Otolaryngol Head Neck Surg, October 1, 2004; 130(10): 1178 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Oda, Y. Shiina, K. Seiki, N. Sato, N. Eguchi, and Y. Urade
Development and Evaluation of a Practical ELISA for Human Urinary Lipocalin-Type Prostaglandin D Synthase
Clin. Chem., September 1, 2002; 48(9): 1445 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. Arrer, C. Meco, G. Oberascher, W. Piotrowski, K. Albegger, and W. Patsch
{beta}-Trace Protein as a Marker for Cerebrospinal Fluid Rhinorrhea
Clin. Chem., June 1, 2002; 48(6): 939 - 941.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. P. Woitas, B. Stoffel-Wagner, U. Poege, P. Schiedermaier, U. Spengler, and T. Sauerbruch
Low-Molecular Weight Proteins as Markers for Glomerular Filtration Rate
Clin. Chem., December 1, 2001; 47(12): 2179 - 2180.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. Bulmer, G. Ward, E. Diamandis, D. Nicol, and J. Clements
Prostaglandin D Synthase Does Not Produce Prostate-specific Antigen Cross-Reactivity in Renal Cell Carcinoma
Clin. Chem., March 1, 2001; 47(3): 607 - 608.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
E. T. Samy, J. C. H. Li, J. Grima, W. M. Lee, B. Silvestrini, and C. Y. Cheng
Sertoli Cell Prostaglandin D2 Synthetase Is a Multifunctional Molecule: Its Expression and Regulation
Endocrinology, February 1, 2000; 141(2): 710 - 721.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Chen, J. D. Morrow, and L. J. Roberts II
Formation of Reactive Cyclopentenone Compounds in Vivo as Products of the Isoprostane Pathway
J. Biol. Chem., April 16, 1999; 274(16): 10863 - 10868.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
C. Sorrentino,, B. Silvestrini,, L. Braghiroli,, S. S.W. Chung,, S. Giacomelli,, M.-G. Leone,, Y.-b. Xie,, Y.-p. Sui,, M.-y. Mo,, and C. Y. Cheng
Rat Prostaglandin D2 Synthetase: Its Tissue Distribution, Changes during Maturation, and Regulation in the Testis and Epididymis
Biol Reprod, October 1, 1998; 59(4): 843 - 853.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Eguchi, N. Eguchi, H. Oda, K. Seiki, Y. Kijima, Y. Matsu-ura, Y. Urade, and O. Hayaishi
Expression of lipocalin-type prostaglandin D synthase (beta -trace) in human heart and its accumulation in the coronary circulation of angina patients
PNAS, December 23, 1997; 94(26): 14689 - 14694.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. P. Diamandis, S. Nadkarni, B. Bhaumik, A. Abdelrahman, D. N. Melegos, G. Borchert, M. H. Black, M. Alonso, A. Salas, J. R. de los Toyos, et al.
Immunofluorometric assay of pepsinogen C and preliminary clinical applications
Clin. Chem., August 1, 1997; 43(8): 1365 - 1371.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Association for Clinical Chemistry.